Sei Investments CO Paratek Pharmaceuticals, Inc. Transaction History

Sei Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 03, 2018	SELL	$10.2 - $13.9 $2,131 - $2,905	-209 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$12.65 - $18.85 $78,493 - $116,964	-6,205 Reduced 96.74%	209 $3,000
Q4 2017 Feb 08, 2018	SELL	$17.45 - $25.6 $44,794 - $65,715	-2,567 Reduced 28.58%	6,414 $114,000
Q3 2017 Nov 06, 2017	BUY	$18.9 - $28.2 $169,740 - $253,264	8,981	8,981 $225,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.